Suspension of trading
Oncternal Therapeutics, Inc. Stock
Stocks
ONCT
US68236P2065
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
08:00:00 03/12/24 am AEDT
|
5-day change | 1st Jan Change | ||
| 0.5266 USD | -24.11% |
|
-.--% | - |
| 01/07/25 | Oncternal Therapeutics, Inc. Appoints Craig R. Jalbert as CEO | CI |
| 01/07/25 | Oncternal Therapeutics, Inc. Announces Management Changes | CI |
| Market Cap | 1.56M 1.34M 1.25M 1.15M 2.16M 149M 2.17M 14.83M 5.8M 75.02M 5.85M 5.73M 248M | P/E 2022 |
-1.19x | P/E 2023 | -0.8x |
|---|---|---|---|---|---|
| Enterprise Value | -32.38M -27.79M -26.02M -23.83M -44.89M -3.09B -45.01M -308M -120M -1.56B -122M -119M -5.16B | EV / Sales 2022 |
-4.9x | EV / Sales 2023 | -2.95x |
| Free-Float |
90.77% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -24.11% |
| 3 years | 0.53 |  | 13.14 |
| 5 years | 0.53 | | 92.6 |
| 10 years | 0.53 | | 211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Vincent
DFI | Director of Finance/CFO | 63 | 01/04/2017 |
Yisrael Katz
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2023 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Hale
CHM | Chairman | 77 | 01/12/2018 |
Dan Kisner
BRD | Director/Board Member | 79 | 07/06/2019 |
William LaRue
BRD | Director/Board Member | 75 | 01/12/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/6/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/6/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/6/24 | Free | Director | 2,200 | 0.0743% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -24.11% | -.--% | -.--% | -92.02% | 1.56M | |
| -0.25% | -0.74% | +3.20% | +23.62% | 51.14B | |
| +2.65% | +4.45% | +481.36% | +567.32% | 47.4B | |
| +0.33% | +2.47% | +38.97% | +19.80% | 43.19B | |
| -0.88% | +0.90% | +24.11% | +87.74% | 42.35B | |
| -2.27% | -3.02% | +14.22% | +51.50% | 33.23B | |
| -1.21% | -0.17% | +29.16% | +135.38% | 17.07B | |
| -0.36% | -2.14% | - | - | 16.38B | |
| -0.38% | -0.16% | +12.15% | +28.39% | 14.76B | |
| +0.44% | +1.70% | +82.07% | +47.92% | 14.15B | |
| Average | -2.60% | -2.02% | +76.14% | +96.63% | 27.97B | |
| Weighted average by Cap. | -0.04% | +1.04% | +106.33% | +143.53% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.49M 1.28M 1.2M 1.1M 2.07M 142M 2.07M 14.18M 5.54M 71.72M 5.59M 5.47M 237M | 785K 674K 631K 578K 1.09M 74.97M 1.09M 7.47M 2.92M 37.79M 2.95M 2.88M 125M |
| Net income | -44.17M -37.92M -35.5M -32.5M -61.23M -4.22B -61.41M -420M -164M -2.13B -166M -162M -7.04B | -39.48M -33.89M -31.73M -29.05M -54.73M -3.77B -54.88M -376M -147M -1.9B -148M -145M -6.29B |
| Net Debt | -63.64M -54.63M -51.14M -46.83M -88.22M -6.08B -88.47M -606M -237M -3.06B -239M -234M -10.14B | -33.94M -29.13M -27.27M -24.97M -47.05M -3.24B -47.18M -323M -126M -1.63B -127M -125M -5.41B |
Employees
29
- Stock Market
- Stocks
- ONCT Stock
Select your edition
All financial news and data tailored to specific country editions
